| Nov 13, 2025 |
Nov 17, 2025 |
Perspective Therapeutics, Inc.
|
Chief Accounting Officer |
Buy |
91.3
|
+11,000
|
22.54%
|
✗
|
$22.3K |
| Nov 25, 2024 |
Nov 27, 2024 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+12,829
|
35.66%
|
✗
|
$49K |
| Jun 17, 2024 |
Jun 18, 2024 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
86.3
|
+1,800
|
5.27%
|
✗
|
$17.7K |
| May 31, 2024 |
Jun 3, 2024 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
86.3
|
+25,006
|
7.90%
|
✗
|
$35K |
| Dec 18, 2023 |
Dec 19, 2023 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+125,000
|
65.20%
|
✗
|
$32.3K |
| Dec 1, 2022 |
Dec 5, 2022 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+85,404
|
80.34%
|
✗
|
$32.5K |
| Jun 7, 2022 |
Jun 9, 2022 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+39,000
|
57.94%
|
✗
|
$11.2K |
| Oct 22, 2020 |
Oct 28, 2020 |
Perspective Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+67,306
|
100.00%
|
✗
|
$35K |